Retinoblastoma protein in human breast carcinoma: Immunohistochemical study using a new monoclonal antibody effective on routinely processed tissues

Journal of Pathology

Volumn 180, Issue 1, 1996, Pages 65-70

  Anderson, John J ^a,b   Tiniakos, Dina G ^a   Mcintosh, Gary G ^a   Autzen, Pernille ^a   Henry, James A ^a   Thomas, Myles D ^a   Reed, J ^a   Horne, Glenda M ^a   Lennard, Thomas W J ^a   Angus, Brian ^a   Horne, Charles H W ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Breast cancer; Immunohistochemistry; Retinoblastoma gene product

Indexed keywords

RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER HORMONE THERAPY; CELL CYCLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE; PHOSPHORYLATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NEOPLASM PROTEINS; PARAFFIN EMBEDDING; PROGNOSIS; RETINOBLASTOMA PROTEIN; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 10244246508     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199609)180:1<65::AID-PATH607>3.0.CO;2-C     Document Type: Article

References (45)

1. Evans HJ, Prosser M. Tumour-suppressor genes: cardinal factors in inherited predisposition to human cancers. Environ Health Perspect 1992; 98: 25-37.
2. Spandidos DA, Anderson MLM. Oncogenes and onco-suppressor genes: their involvement in cancer. J Pathol 1987; 157: 1-10.
3. Hong FD, Huang HJS, To H, et al. Structure of the human retinoblastoma gene. Proc Natl Acad Sci USA 1989; 86: 5502-5506.
4. Cavenee WK, Hansen MF, Nordenskjold M, et al. Genetic origin of mutations predisposing to retinoblastoma. Science 1985; 228: 501-503.
5. Bernards R, Schackleford GM, Gerber MR, et al. Structure and expression of the murine retinoblastoma gene and characterisation of its encoded product. Proc Natl Acad Sci USA 1989; 86: 6474-6478.
6. Cordon-Cardo C, Richon VM. Expression of the retinoblastoma protein is regulated in normal human tissues. Am J Pathol 1994; 144: 500-510.
7. Chittenden T, Livingston DM, Kaelin WG Jr. The ElA-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA binding protein. Cell 1991; 65: 1073-1082.
8. Mittnacht S, Weinberg RA. G1/S phosphorylation of the retinoblastoma gene product is associated with an altered affinity for the nuclear compartment. Cell 1991; 65: 381-393.
9. DeCaprio JA, Ludlow JW, Figge J, et al. SV40 large tumour antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988; 54: 275-283.
10. Whyte P, Buchkovich KJ, Horowitz JM, et al. Association between an oncogene and an anti-oncogene: the adenovirus ElA proteins bind to the retinoblastoma gene product. Nature 1988; 334: 124-129.
11. Dyson N, Howley PM, Munger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243: 934-937.
12. Marx J. How the retinoblastoma gene may inhibit cell growth. Science 1991; 252: 1492.
13. Hansen MF, Koufos A, Gallie BL, et al. Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci USA 1985; 82: 6216-6220.
14. Wadayama B, Toguchida J, Shimizu T, et al. Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res 1994; 54: 3042-3048.
15. Stratton MR, Williams S, Fisher C, et al. Structural alterations of the RB1 gene in human soft tissue tumours. Br J Cancer 1989; 60: 202-205.
16. Harbour JW, Lai S-L, Whang-Peng J, et al. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 1988; 241: 353-357.
17. Xu HJ, Quinlan DC, Davidson AG, et al Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma. J Natl Cancer Inst 1994; 86: 695-699.
18. Horowitz JM, Yandell DW, Park S-H, et al. Point mulational inactivation of the retinoblastoma anti-oncogene. Science 1989; 243: 937-940.
19. Ginsberg AM, Raffeld M, Cossman J. Inactivation of the retinoblastoma gene in human lymphoid neoplasms. Blood 1991; 77: 833-840.
20. Weide R, Tiemann M, Pfluger KH, et al. Altered expression of the retinoblastoma gene product in human high grade non-Hodgkin's lymphomas. Leukemia 1994; 8: 97-101.
21. Lee EY-HP, To H, Shew J-Y, et al. Inactivation of the retinoblastoma gene in human breast carcinoma. Science 1988; 241: 218-221.
22. T'Ang A, Varley JM, Chakraborty S, et al. Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science 1988; 242: 263-266.
23. Varley JM, Armour J, Swallow JE, et al. The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours. Oncagene 1989; 4: 725-729.
24. Borg A, Zhang QX, Aim P, Olsson H, Sellberg G. The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression. Cancer Res 1992; 52: 2991-2994.
25. Hopp TP, Woods KR. Prediction of antigenic determinants from aminoacid sequences. Proc Natl Acad Sci USA 1981; 78: 3824-3828.
26. Sweet RM, Eisenberg D. Correlation of sequence hydrophobicities measures similarity in 3-dimensional protein structure. J Mol Biol 1983; 171: 479-488.
27. Gamier J, Osguthorpe DJ, Robson B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of proteins from their amino-acid sequences. J Mol Biol 1978; 120: 97-120.
28. Chou PY, Fasman GD. Prediction of the secondary structure of proteins from their amino-acid sequence. Adv Enzymol 1978; 47: 45-148.
29. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-410.
30. Henry L, Angus B, Lennard TWJ, et al. New monoclonal antibodies to oestrogen and progesterone receptor: characterisation and clinical studies in human breast cancer. J Pathol 1993; 169 (Suppl): 168A.
31. Piggott NH, Henry JA, May FEB, Westley BR. Antipeptide antibodies against the pNR-2 oestrogen-regulated protein of human breast cancer cells and detection of pNR-2 expression in normal tissues by immunohistochemistry. J Pathol 1991; 163: 95-104.
32. Corbett IP, Henry JA, Angus B, et al. NCL-CB11, a new monoclonal antibody recognising the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissues. J Pathol 1990; 161: 15-25.
33. Tiniakos D, Scott L, Corbett IP, Piggott NH, Home CHW. Studies of c-jun oncogene expression in human breast using a new monoclonal antibody. NCL-DK4. J Pathol 1994; 172: 19-26.
34. Home GM, Anderson JJ, Tiniakos D, Angus B, Home CHW. Tumour suppressor gene expression in routinely-processed human breast carcinomas. J Pathol 1994; 172 (Suppl): s122.
35. Henry JA, Piggott NH, Mallick UK, et al. pNR-2/pS2 immunohistochemical staining on breast cancer: correlation with prognostic factors and endocrine response. Br J Cancer 1991; 63: 615-622.
36. Wang NP, To H, Lee WH, Lee EY. Tumour suppressor activity of RB and p53 genes in human breast carcinoma cells. Oncogene 1993; 8: 279-288.
37. Walker RA, Dearing SJ, Lane DP, Varley JM. Expression of p53 protein in infiltrating and in-situ breast carcinomas. J Pathol 1991; 165: 203-211.
38. Sawan A, Randall B, Angus B, et al. Retinoblastoma and p53 gene expression related to relapse and survival in human breast cancer: an immunohistochemical study. J Pathol 1992; 168: 23-28.
39. Smith R, Shousha S, Luqmani Y, Coope R, Shepard HM, Feldmann M. Retinoblastoma protein in node negative breast carcinoma. J Pathol 1994; 172 (Suppl): 123.
40. Yamashita H, Kobayashi S, Iwase H, et al. Analysis of oncogenes and tumour suppressor genes in human breast cancer. Jpn J Cancer Res 1993; 84: 871-878.
41. Spandidos DA, Karaiossifldi H, Malliri A, et al. Expression of ras, Rb1 and p53 proteins in human breast cancer. Anticancer Res 1992; 12: 81-90.
42. Trudel M, Mulligan L, Cavernee W, et al. Retinoblastoma and p53 gene product expression in breast carcinoma. Hum Pathol 1992; 23: 1388-1394.
43. McIntosh GG, Anderson JJ, Milton I, et al. Determination of the prognos-tic value of cyclin D1 expression in breast cancer. Oncogene 1995; 11: 885-891.
44. MacKay J, Steel CM, Elder DA, Forest APM, Evans HJ. Allele loss on short arm of chromosome 17 in breast cancers. Lancet 1988; ii: 1384-1385.
45. Metin A, Hung MC. The retinoblastoma gene product, Rb, represses neu expression through two regions within the neu regulatory sequence. Oncogene 1994; 9: 1333-1339.